NCT04399096

Brief Summary

Sound and Vision: A collaboration between service-users, artists and the public to explore the lived experience of hallucinations

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2020

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 13, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 22, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

April 28, 2021

Status Verified

April 1, 2021

Enrollment Period

1 year

First QC Date

May 13, 2020

Last Update Submit

April 27, 2021

Conditions

Keywords

hallucination

Outcome Measures

Primary Outcomes (2)

  • University of Miami Parkinson's disease Hallucinations Questionnaire (UM-PDHQ)

    The University of Miami Parkinson's disease Hallucinations Questionnaire (UM-PDHQ) is composed of 6 quantitative and 14 qualitative items to define the key characteristics of hallucinations in Parkinson's Disease. The first 6 questions score the severity of hallucinations with a minimum score is zero and a maximum of 14, with greater score indicating greater severity. The remaining 14 questions have qualitative answers.

    Through study completion, an average of 1 year

  • The Multi-Modality Unusual Sensory Experiences Questionnaire (MUSEQ)

    The Multi-Modality Unusual Sensory Experiences Questionnaire (MUSEQ) is a 43-item self-report measure with each item rated on a five-point Likert scale, and assesses unusual sensory experiences in six modalities: auditory, visual, olfactory, gustatory, bodily sensations, and sensed presence. The minimum score is zero, the maximum score is 173 with a greater score indicating a higher frequency of unusual sensory experiences.

    Through study completion, an average of 1 year

Study Arms (1)

General population

The general public attending exhibitions of the artworks who wish to complete the on-line questionnaire and feedback

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The general publication attending an exhibition of artworks depicting the experience of hallucinations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cambridge and Peterborough NHS Trust

Cambridge, Cambs, United Kingdom

RECRUITING

Cambridge University Hospital

Cambridge, Cambs, United Kingdom

RECRUITING

Related Publications (1)

  • Rollins CPE, Garrison JR, Simons JS, Rowe JB, O'Callaghan C, Murray GK, Suckling J. Meta-analytic Evidence for the Plurality of Mechanisms in Transdiagnostic Structural MRI Studies of Hallucination Status. EClinicalMedicine. 2019 Feb 21;8:57-71. doi: 10.1016/j.eclinm.2019.01.012. eCollection 2019 Feb.

    PMID: 31193632BACKGROUND

MeSH Terms

Conditions

SchizophreniaParkinson DiseaseHallucinations

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersParkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • John Suckling

    University of Cambridge

    PRINCIPAL INVESTIGATOR
  • Emilio Fernandez-Egea

    Cambridgeshire and Peterborough NHS Foundation Trust

    PRINCIPAL INVESTIGATOR
  • James Rowe

    Cambridge University Hospitals NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

John Suckling

CONTACT

Colleen Rollins

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Research in Psychiatric Neuroimaging

Study Record Dates

First Submitted

May 13, 2020

First Posted

May 22, 2020

Study Start

December 1, 2020

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

April 28, 2021

Record last verified: 2021-04

Locations